ONCOSIGNAL
DEAD

Serial Number

97743114

Owner

InnoSIGN B.V.

Attorney

Abigail D. LeCroy

Filing Date

Jan 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ONCOSIGNAL Trademark

Serial Number: 97743114

ONCOSIGNAL is a trademark filed by InnoSIGN B.V. on January 5, 2023. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

InnoSIGN B.V. (3 trademarks)

High Tech Campus 11
Eindhoven NL-5656AE , NL

Entity Type: 99

Trademark Details

Filing Date

January 5, 2023

Registration Date

Not Registered

Published for Opposition

August 19, 2025

Goods & Services

Scientific and technological services, namely, analysis and testing in the field of DNA, RNA, genetics, cell biology and PCR ; quality control for others and authentication services in the field of DNA, RNA and PCR testing and measurement and associated data validation; medical and pharmaceutical research services; design and development of medical testing and analysis methods; medical and genetic research and development of drugs and treatment methods for diseases; design and development of diagnostic equipment, instruments and test procedures for medical and pharmaceutical purposes; genetic data mining; designing, developing, testing, programming, installing, updating, upgrading, implementing, maintaining and providing temporary use of online non-downloadable software and computer programs for accessing databases, portals and platforms; information technology services for the pharmaceutical and healthcare industry, namely, data security and hosting services and analysis of genetic and RNA sequencing data files and data validation; development of computer programs for use in the field of medicine and health care; technical advice relating to the design of computer hardware and software relating to the aforesaid analysis of genetic and RNA sequencing data files and data validation services, providing scientific research information relating to medical diagnostic and testing via electronic networks such as the Internet

Chemical products for scientific purposes; biological preparations for use in science; diagnostic preparations for clinical or medical laboratory purposes; diagnostic preparations for research laboratory use; reagents for scientific or research purposes, including medical research

Scientific, research and teaching apparatus, instruments and simulators, namely, centrifuges used as laboratory apparatus, laboratory thermocyclers for real time PCR detection, PCR plate foils, RT-qPCR testing plates, PCR test plates, medical diagnostic simulators for use as teaching aids for real time or quantitative PCR and analysis, and medical laboratory research instruments for detecting DNA; laboratory test equipment, namely, PCR plate foils, RT-qPCR testing plates, PCR test plates for use in diagnostic testing, not for medical purposes; analyzers for use in research laboratories for measuring, testing and analyzing bodily materials, namely, blood and other bodily fluids containing DNA; electrical apparatus for the genetic modification of cells for research purposes; quantitative and real time polymerase chain reaction (PCR) instruments for scientific use; data processing equipment; recorded or downloadable software, software platforms, software packages and software applications for collecting and analyzing data, in the field of medical and diagnostic testing; downloadable electronic publications, namely, books, periodicals, magazines, newspapers, pamphlets, brochures, publications, educational and teaching materials in the field of medical and diagnostic testing; media content, namely, downloadable educational multimedia files, featuring medical and diagnostic testing; downloadable podcasts in the field of medical and diagnostic testing; parts of the aforesaid goods

Medical and healthcare services; medical and healthcare testing services relating to the diagnosis and treatment of disease; conducting medical examinations and tests for diagnostic or treatment purposes; medical and health services in the field of DNA, RNA, genetics and genetic testing; medical and health advice, consultancy and information relating to the aforesaid services via electronic networks such as the Internet

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 18, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 18, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 10, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 10, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 10, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 10, 2025 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 10, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 1, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2024 CRFA
ASSIGNED TO LIE
Jun 27, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2023 TROA
NOTICE OF REVIVAL - E-MAILED
Dec 30, 2023 NREV
NOTICE OF REVIVAL - E-MAILED
Dec 30, 2023 NREV
PETITION TO REVIVE-GRANTED
Dec 30, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 30, 2023 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 29, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2023 NWOS
NEW APPLICATION ENTERED
Jan 9, 2023 NWAP